Edap Tms (NASDAQ:EDAP) Lifted to Buy at ValuEngine
EDAP has been the topic of a number of other reports. HC Wainwright set a $7.00 price objective on shares of Edap Tms and gave the company a buy rating in a research note on Friday, August 30th. Zacks Investment Research upgraded shares of Edap Tms from a sell rating to a hold rating in a research report on Tuesday, July 16th. Finally, TheStreet downgraded Edap Tms from a b- rating to a d+ rating in a research note on Monday, June 17th.
Edap Tms stock opened at $3.63 on Friday. The company has a market cap of $107.29 million, a PE ratio of 52.86 and a beta of 1.87. The company has a current ratio of 2.40, a quick ratio of 1.97 and a debt-to-equity ratio of 0.09. Edap Tms has a 1 year low of $1.35 and a 1 year high of $5.42. The company’s 50-day moving average is $3.17 and its two-hundred day moving average is $3.35.
Several hedge funds have recently made changes to their positions in the company. Hilton Capital Management LLC bought a new position in Edap Tms during the 1st quarter worth approximately $75,000. JPMorgan Chase & Co. bought a new stake in Edap Tms in the second quarter valued at approximately $282,000. Susquehanna International Group LLP increased its stake in Edap Tms by 762.9% in the second quarter. Susquehanna International Group LLP now owns 205,178 shares of the medical equipment provider’s stock valued at $556,000 after purchasing an additional 181,401 shares in the last quarter. Acadian Asset Management LLC bought a new stake in Edap Tms in the second quarter valued at approximately $607,000. Finally, Morgan Stanley raised its holdings in Edap Tms by 222.7% in the second quarter. Morgan Stanley now owns 267,408 shares of the medical equipment provider’s stock worth $722,000 after purchasing an additional 184,539 shares during the period. 13.24% of the stock is owned by institutional investors.
Edap Tms Company Profile
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
Featured Story: Percentage Decliners
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.